Rxsight Inc RXST

$4.68 -0.07 (-1.47%)

Valuation

Market cap
194,655,000
Revenue TTM
$134,480,000
Net income TTM
$-38,940,000
PE ratio
0.00
Forward PE
—
Profit margin
-28.96%
Debt to equity
0.00

Trading

Volume
616,800
Avg volume
845,322
Day's range
$4.63 – $4.77
Shares out
41,593,000
Stochastic %K
13%
Beta
1.15
Analysts
Hold
Price target
$7.57

Price

Company profile

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an...

Show more

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Industry
Medical Devices
Sector
Healthcare
Phone
949 521 7830
Website
https://rxsight.com
Address
100 Columbia, Aliso Viejo, United States

Latest news

No headlines yet.